CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A /

CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing.Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution.

Bibliographic Details

Main Author:	Singh, Vijay, 1950- (Author)
Corporate Author:	ScienceDirect (Online service)
Format:	eBook
Language:	English
Published:	London, England : Academic Press, [2024]
Edition:	First edition.
Series:	Progress in Molecular Biology and Translational Science Series.
Subjects:	Gene therapy. Genetic Therapy Thérapie génique. Electronic books.
Online Access:	Connect to the full text of this electronic book